Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sarah Demortiere"'
Autor:
Bertrand Audoin, Sarah Demortiere, Penelope Tilsley, Ruben Attia, Ruben Fitoussi, Kevin Mairot, Jan-Patrick Stellman, Thierry David, Natacha Stolowy
Publikováno v:
BMJ Open Ophthalmology, Vol 8, Iss 1 (2023)
Background The aim of this study was to assess the risk factors for atrophic progression of patients with papilloedema secondary to intracranial hypertension, using optical coherence tomography parameters.Methods A retrospective study was conducted a
Externí odkaz:
https://doaj.org/article/9e026cf491914bb6a9c7eb9fd7fc260c
Autor:
Sarah Demortiere, Audrey Rico, Clemence Boutiere, Jean Pelletier, Bertrand Audoin, Adil Maarouf
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2021, 27 (5), pp.712-718. ⟨10.1177/1352458520912637⟩
Multiple Sclerosis Journal, 2021, 27 (5), pp.712-718. ⟨10.1177/1352458520912637⟩
Background: Planning pregnancy in patients with active multiple sclerosis (MS) is highly challenging because treatment withdrawn may be associated with dramatic disease reactivation. Objective: To compare two strategies for women with active MS who w
Autor:
Marine Perriguey, Jan-Patrick Stellmann, Adil Maarouf, Pierre Durozard, Sarah Demortiere, Jean Pelletier, Audrey Rico, Clemence Boutiere, Bertrand Audoin
Publikováno v:
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1115. ⟨10.1212/NXI.0000000000001115⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1115. ⟨10.1212/NXI.0000000000001115⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Background and ObjectivesTo determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).MethodsThis prospective observational study included all consecutive PwMS receiving RTX a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a83941d2bcccd9d9a49e71db9a3b358
https://amu.hal.science/hal-03537471
https://amu.hal.science/hal-03537471
Autor:
Toscane Fourié, Sarah Demortiere, Jean Pelletier, Bertrand Audoin, Audrey Rico, Xavier de Lamballerie, Clemence Boutiere, Paola Mariela Saba Villarroel, Laetitia Ninove, Abdennour Amroun, Adil Maarouf, Pierre Durozard
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
We studied the serologic response to the BNT162b2 mRNA vaccine at four weeks after the second dose in patients with RRMS treated with rituximab with extended-interval dosing ( n = 26). At four weeks, 73% of patients were seropositive. No patient with
Autor:
Romain Marignier, Thomas Sené, Sarah Demortiere, Jean Pelletier, Jean Capron, Bertrand Audoin, Mathieu Vaillant, Frédéric Hilezian, Claire Giannesini, Géraldine Androdias, Philippe Kerschen, Olivier Casez, Adil Maarouf, Jonathan Ciron, Guillaume Mathey, Jean-Philippe Camdessanché, Arsène Mekinian, Catalina Coclitu, Nicolas Collongues, Caroline Bensa-Koscher, Audrey Rico, Clemence Boutiere
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, 2021, jnnp-2020-325665. ⟨10.1136/jnnp-2020-325665⟩
Journal of Neurology, Neurosurgery and Psychiatry, BMJ Publishing Group, 2021, jnnp-2020-325665. ⟨10.1136/jnnp-2020-325665⟩
Journal of Neurology, Neurosurgery, and Psychiatry
Journal of Neurology, Neurosurgery and Psychiatry, 2021, jnnp-2020-325665. ⟨10.1136/jnnp-2020-325665⟩
Journal of Neurology, Neurosurgery and Psychiatry, BMJ Publishing Group, 2021, jnnp-2020-325665. ⟨10.1136/jnnp-2020-325665⟩
Journal of Neurology, Neurosurgery, and Psychiatry
International audience; Objective To assess the efficacy of tumour necrosis factor-α (TNF-α) inhibitors used as steroid-sparing monotherapy in central nervous system (CNS) parenchymal sarcoidosis. Methods The French Multiple Sclerosis and Neuroinfl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082f8cb01a1d3da53235ad381528a70e
https://hal.sorbonne-universite.fr/hal-03256908/document
https://hal.sorbonne-universite.fr/hal-03256908/document
Autor:
Sarah Demortiere, Jean Pelletier, Romain Marignier, Alexandre Avouac, Bertrand Audoin, Audrey Rico, Clemence Boutiere, Adil Maarouf, Jan-Patrick Stellmann
Publikováno v:
Neurology-Neuroimmunology Neuroinflammation
Neurology-Neuroimmunology Neuroinflammation, 2021, 8, ⟨10.1212/nxi.0000000000000977⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology-Neuroimmunology Neuroinflammation, 2021, 8, ⟨10.1212/nxi.0000000000000977⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
ObjectiveTo determine the potential association between infections and rituximab (RTX)-induced hypogammaglobulinemia among patients with CNS inflammatory diseases.MethodsWe included in a prospective observational study all consecutive adults with aqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6fe7c84e76a145fff3faefe42ea3cb
https://hal.archives-ouvertes.fr/hal-03186457
https://hal.archives-ouvertes.fr/hal-03186457
Autor:
Zélia Poullet, Julie Pique, Adil Maarouf, Clemence Boutiere, Audrey Rico, Sarah Demortiere, Pierre Durozard, Caroline Papeix, Elisabeth Maillart, Nicolas Collongues, Xavier Ayrignac, Helene Zephir, Romain Deschamps, Jonathan Ciron, Jean Pelletier, Romain Marignier, Bertrand Audoin
Publikováno v:
Neurology - Neuroimmunology Neuroinflammation. 9:e1167
Background and ObjectivesPure relapsing short myelitis with clinical and paraclinical features suggesting multiple sclerosis (MS) has been described recently. Here, we evaluated the existence of this potential new form of MS by retrospectively search
Autor:
Clarisse Carra Dallière, Safa Aouinti, Sarah Demortiere, Kévin Bigaut, Laurent Kremer, Mahmoud Charif, Jérôme De Seze, Jean Pelletier, Xavier Ayrignac, Adil Maarouf, Marie Christine Picot, Nicolas Collongues, Frédéric Pinna, Pierre Labauge
Publikováno v:
Multiple sclerosis and related disorders. 48
The advent of new, potent, disease-modifying therapies has dramatically changed the management of multiple sclerosis (MS). Along with these possibilities, it is crucial to better recognize patients who are at risk of first line treatment (FLT) failur
Autor:
Bertrand Audoin, Sarah Demortiere, Maxime Guye, A. Trabelsi, Olivier M. Girard, J.P. Ranjeva, Jean Pelletier, Virginie Callot, Henitsoa Rasoanandrianina, Guillaume Duhamel
Publikováno v:
American Journal of Neuroradiology
American Journal of Neuroradiology, 2020, 41 (5), pp.929-937. ⟨10.3174/ajnr.A6554⟩
American Journal of Neuroradiology, American Society of Neuroradiology, 2020, 41 (5), pp.929-937. ⟨10.3174/ajnr.A6554⟩
AJNR Am J Neuroradiol
American Journal of Neuroradiology, 2020, 41 (5), pp.929-937. ⟨10.3174/ajnr.A6554⟩
American Journal of Neuroradiology, American Society of Neuroradiology, 2020, 41 (5), pp.929-937. ⟨10.3174/ajnr.A6554⟩
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: The inhomogeneous magnetization transfer technique has demonstrated high specificity for myelin, and has shown sensitivity to multiple sclerosis-related impairment in brain tissue. Our aim was to investigate its sensitivity to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a278f86a35e10bb240c726ce74c19f47
https://hal-amu.archives-ouvertes.fr/hal-02869168/file/929.full.pdf
https://hal-amu.archives-ouvertes.fr/hal-02869168/file/929.full.pdf
Autor:
Bertrand Audoin, Adil Maarouf, Jean Pelletier, Audrey Rico, Clemence Boutiere, Marine Perriguey, Sarah Demortiere
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, 2020, 7 (5), pp.e825. ⟨10.1212/NXI.0000000000000825⟩
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, 2020, 7 (5), pp.e825. ⟨10.1212/NXI.0000000000000825⟩
ObjectiveTo evaluate disease activity in patients with relapsing-remitting MS (RRMS) receiving rituximab with an extended dosing interval.MethodsIn the context of COVID-19 pandemic, this was an interim analysis of an ongoing prospective observational